Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Burdette

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Skinmed|May 14, 2005
With this eruption, there is not a second to luesSteven D Burdette, Jill S Waibel, Jack M Bernstein, et al.
Journal of Hospital Medicine|April 16, 2010
Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortalityEmilio V Perez-Jorge, Steven D Burdette, Ronald J Markert, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2014
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levelsSteven D Burdette, Frederick Oleson, Patrick M McDaneld, et al.
Pharmacotherapy|May 8, 2013
Ceftaroline-induced eosinophilic pneumoniaKunal R Desai, Steven D Burdette, Hari M Polenakovik, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2009
Serum concentrations of aerosolized tobramycin in medical, surgical, and trauma patientsSteven D Burdette, Ashley J Limkemann, Jonathan B Slaughter, et al.
The Journal of Infection|January 24, 2012
Staphylococcus aureus pyomyositis compared with non-Staphylococcus aureus pyomyositisSteven D Burdette, Richard R Watkins, Ken K Wong, et al.
Injury|July 13, 2023
Use of single agent Cefotetan for Gustilo-Anderson type III open fracture prophylaxisGarrhett G Via, David A Brueggeman, Victoria A Murray, et al.
Journal of Global Antimicrobial Resistance|January 17, 2018
DISC: Describing Infections of the Spine treated with CeftarolineRichard R Watkins, George Yendewa, Steven D Burdette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care SettingSarah B Doernberg, Lilian M Abbo, Steven D Burdette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 15, 2018
Early Infectious Diseases Specialty Intervention Is Associated With Shorter Hospital Stays and Lower Readmission Rates: A Retrospective Cohort StudySteven Schmitt, Ann T MacIntyre, Susan C Bleasdale, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Skinmed|May 14, 2005
With this eruption, there is not a second to luesSteven D Burdette, Jill S Waibel, Jack M Bernstein, et al.
Journal of Hospital Medicine|April 16, 2010
Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortalityEmilio V Perez-Jorge, Steven D Burdette, Ronald J Markert, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2014
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levelsSteven D Burdette, Frederick Oleson, Patrick M McDaneld, et al.
Pharmacotherapy|May 8, 2013
Ceftaroline-induced eosinophilic pneumoniaKunal R Desai, Steven D Burdette, Hari M Polenakovik, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2009
Serum concentrations of aerosolized tobramycin in medical, surgical, and trauma patientsSteven D Burdette, Ashley J Limkemann, Jonathan B Slaughter, et al.
The Journal of Infection|January 24, 2012
Staphylococcus aureus pyomyositis compared with non-Staphylococcus aureus pyomyositisSteven D Burdette, Richard R Watkins, Ken K Wong, et al.
Injury|July 13, 2023
Use of single agent Cefotetan for Gustilo-Anderson type III open fracture prophylaxisGarrhett G Via, David A Brueggeman, Victoria A Murray, et al.
Journal of Global Antimicrobial Resistance|January 17, 2018
DISC: Describing Infections of the Spine treated with CeftarolineRichard R Watkins, George Yendewa, Steven D Burdette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care SettingSarah B Doernberg, Lilian M Abbo, Steven D Burdette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 15, 2018
Early Infectious Diseases Specialty Intervention Is Associated With Shorter Hospital Stays and Lower Readmission Rates: A Retrospective Cohort StudySteven Schmitt, Ann T MacIntyre, Susan C Bleasdale, et al.
Pageof 4